Body mass weighted prostate-specific antigen levels, new markers to predict locally advanced prostate cancer after prostatectomy.

Ying-Lun Ou, Ming-Hsin Yang, Chien-Chang Kao, En Meng, Jin-Li Chen, Chih-Wei Tsao, Guang-Huan Sun, Dah-Shyong Yu, Tai-Lung Cha, Sheng-Tang Wu
{"title":"Body mass weighted prostate-specific antigen levels, new markers to predict locally advanced prostate cancer after prostatectomy.","authors":"Ying-Lun Ou, Ming-Hsin Yang, Chien-Chang Kao, En Meng, Jin-Li Chen, Chih-Wei Tsao, Guang-Huan Sun, Dah-Shyong Yu, Tai-Lung Cha, Sheng-Tang Wu","doi":"10.1097/JCMA.0000000000001109","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Prostate-specific antigen (PSA) remains the most useful marker for screening, risk categorization, and follow-up in patients with prostate cancer. In the obese population, several studies have revealed that obesity may not only inversely interfere with the concentration of PSA, but also increase the risk of prostate cancer. Thus, we considered using the body mass weighted PSA levels, presented as serum PSA concentration multiplied by body weight or body mass index (BMI), instead of traditional PSA concentration, as potential markers to predict locally advanced prostate cancer after prostatectomy.</p><p><strong>Methods: </strong>We retrospectively collected and analyzed data acquired from a single institute at which robot-assisted laparoscopic radical prostatectomy was performed. A total of 174 patients underwent radical prostatectomy, and the collected data included age, PSA level, body weight, BMI, and pathology results.</p><p><strong>Results: </strong>A total of 174 patients were diagnosed with adenocarcinoma of the prostate by needle biopsy, and most (N = 165) were considered to have localized disease on preoperative multiparameter magnetic resonance imaging. After prostatectomy, 73% (N = 127) of the patients remained in the localized disease group (group A) and 27% (N = 47) of the patients were reclassified to the locally advanced prostate cancer (group B). The value of PSA was higher in group B (16.9 vs 11.2 ng/dL; p = 0.062), but there was no statistically significant difference between the two groups. After using the numerical values of PSA × body weight and PSA × BMI, a statistically significant difference emerged between the two groups ( p = 0.0198 in PSA × BW; p = 0.0110 in PSA × BMI).</p><p><strong>Conclusion: </strong>The body mass-weighted PSA levels, instead of the traditional PSA concentration, may be better markers for predicting non-organ-confined disease after surgery. It may also be useful in screening and risk categorization.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"799-802"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Chinese Medical Association : JCMA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/JCMA.0000000000001109","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/17 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Prostate-specific antigen (PSA) remains the most useful marker for screening, risk categorization, and follow-up in patients with prostate cancer. In the obese population, several studies have revealed that obesity may not only inversely interfere with the concentration of PSA, but also increase the risk of prostate cancer. Thus, we considered using the body mass weighted PSA levels, presented as serum PSA concentration multiplied by body weight or body mass index (BMI), instead of traditional PSA concentration, as potential markers to predict locally advanced prostate cancer after prostatectomy.

Methods: We retrospectively collected and analyzed data acquired from a single institute at which robot-assisted laparoscopic radical prostatectomy was performed. A total of 174 patients underwent radical prostatectomy, and the collected data included age, PSA level, body weight, BMI, and pathology results.

Results: A total of 174 patients were diagnosed with adenocarcinoma of the prostate by needle biopsy, and most (N = 165) were considered to have localized disease on preoperative multiparameter magnetic resonance imaging. After prostatectomy, 73% (N = 127) of the patients remained in the localized disease group (group A) and 27% (N = 47) of the patients were reclassified to the locally advanced prostate cancer (group B). The value of PSA was higher in group B (16.9 vs 11.2 ng/dL; p = 0.062), but there was no statistically significant difference between the two groups. After using the numerical values of PSA × body weight and PSA × BMI, a statistically significant difference emerged between the two groups ( p = 0.0198 in PSA × BW; p = 0.0110 in PSA × BMI).

Conclusion: The body mass-weighted PSA levels, instead of the traditional PSA concentration, may be better markers for predicting non-organ-confined disease after surgery. It may also be useful in screening and risk categorization.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
体重加权 PSA 水平是预测前列腺切除术后局部晚期前列腺癌的新指标。
背景:前列腺特异性抗原(PSA)仍然是筛查、风险分类和随访前列腺癌患者最有用的标志物。在肥胖人群中,多项研究表明,肥胖不仅会对 PSA 的浓度产生反向干扰,还会增加前列腺癌的风险。因此,我们考虑使用体重加权 PSA 水平(即血清 PSA 浓度乘以体重或体重指数)来替代传统的 PSA 浓度,作为预测前列腺切除术后局部晚期前列腺癌的潜在标志物:我们回顾性地收集并分析了在一家研究所进行的机器人辅助腹腔镜前列腺癌根治术的数据。共有 174 名患者接受了前列腺癌根治术,收集的数据包括年龄、PSA 水平、体重、BMI 和病理结果:共有 174 名患者通过针刺活检确诊为前列腺腺癌,其中大多数(165 人)在术前多参数磁共振成像中被认为是局部病变。前列腺切除术后,73%(127 人)的患者仍属于局部病变组(A 组),27%(47 人)的患者被重新分类为局部晚期前列腺癌(B 组)。B 组患者的 PSA 值更高(16.9 vs 11.2 ng/dL;P= 0.062),但两组之间的差异无统计学意义。在使用 PSA x 体重和 PSA x BMI 的数值后,两组之间出现了统计学意义上的显著差异(PSA × 体重的 p= 0.0198;PSA × BMI 的 p=0.0110):结论:体重加权 PSA 水平,而非传统的 PSA 浓度,可能是预测术后非器官封闭性疾病的更好指标。结论:体质加权 PSA 水平可能比传统的 PSA 浓度更适合作为预测术后非器官封闭性疾病的指标,在筛查和风险分类方面也可能有用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Onyx as an adjunctive embolic material for transvenous embolization of cavernous sinus dural arteriovenous fistula after coiling. Postoperative rhinosinusitis and microbiological outcomes following endoscopic endonasal approaches: A retrospective analysis of 300 patients. Real-world outcomes of everolimus-based treatment in a Taiwanese cohort with metastatic HR+/HER2- breast cancer. A prediction model of echocardiographic variables to screen for potentially correctable shunts in adult ASD-PAH patients. Risk factors for screw loosening in patients with lumbar degenerative spondylolisthesis treated with Dynesys dynamic stabilization.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1